July 22, 2024 – Talk Bio

Grünenthal Acquires US-Based Valinor Pharma for $250 Million

9 months ago talkbio0Tagged Acquisition, Drug Industry, expansion, Grünenthal, Market, Movantik, naloxegol, Pain management, Pharma, U.S., Valinor

Grünenthal, Valinor Pharma, acquisition, Movantik, naloxegol, opioid-induced constipation, pain management, US market expansion, pharmaceutical industry

SEC Staff Recommends Enforcement Action Against Allarity Over Potential Federal Securities Laws Violations

9 months ago talkbio0Tagged Allarity, Clinical action, Dovitinib, enforcement, federal, Rules of conduct, seconds, stenoparib, United States Food and Drug Administration, Violations

Allarity Therapeutics, SEC, Enforcement Action, Federal Securities Laws, Violations, Wells Notice, FDA, Dovitinib, Stenoparib

Eli Lilly, Novo Nordisk Shares Fall as their weight-Loss drugs face competition

9 months ago talkbio0Tagged CT-996, Eli, Eli Lilly, Glucagon-Like Peptide 1, Nordisk, Obesity, Pharmaceutical competition, Roche, Stock market, Wegovy, weight-loss drug market

, Eli Lilly, Novo Nordisk, Roche, Obesity drugs, Weight-loss drug market, Stock market, Pharmaceutical competition, GLP-1 therapy, CT-996, Zepbound, Wegovy,